Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy Improves Survival in Unresectable Esophageal Cancer: a systematic review, meta-analysis, and network meta-analysis - Top-Institutions - MDSpire

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy Improves Survival in Unresectable Esophageal Cancer: a systematic review, meta-analysis, and network meta-analysis

  • By

  • Fan, Xuefei

  • Liu, Xin

  • Song, Mi

  • Yang, Yunxin

  • Li, Chenggong

  • Zhang, Jiandong

  • Hu, Pingping

  • April 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Sichuan Cancer Hospital and Institute
    Sichuan Cancer Hospital and Institute

    Chengdu, Sichuan

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

  • #4

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Oncology

Original Source(s)

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy Improves Survival in Unresectable Esophageal Cancer: a systematic review, meta-analysis, and network meta-analysis

  • by Fan, Xuefei , Liu, Xin , Song, Mi , Yang, Yunxin , Li, Chenggong , Zhang, Jiandong , Hu, Pingping

  • April 27, 2026

Related Content

Advanced dose calculation strategies for clinical linear accelerators: a systematic review

Assessment of the mechanical performance of a novel CT-linac treatment couch

Beyond Treatment Volume: When Pelvic Radiotherapy May Still Matter in High-Risk Localised Prostate Cancer